BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin J, Tang S, Xia L, Du R, Xie H, Song J, Fan R, Bi Q, Chen Z, Yang G, Liu J, Shi Y, Fan D. MicroRNA-501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun 2013;430:1228-33. [PMID: 23266610 DOI: 10.1016/j.bbrc.2012.12.071] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Finch ML, Marquardt JU, Yeoh GC, Callus BA. Regulation of microRNAs and their role in liver development, regeneration and disease. Int J Biochem Cell Biol. 2014; Apr 13. [Epub ahead of print]. [PMID: 24731940 DOI: 10.1016/j.biocel.2014.04.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
2 Aryani A, Denecke B. In vitro application of ribonucleases: comparison of the effects on mRNA and miRNA stability. BMC Res Notes 2015;8:164. [PMID: 25899823 DOI: 10.1186/s13104-015-1114-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
3 Wang Y, Cao J, Zhang S, Sun L, Nan Y, Yao H, Fan J, Zhu LY, Yu L. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma. Cell Death Dis 2019;10:783. [PMID: 31611549 DOI: 10.1038/s41419-019-1999-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
4 Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, Huang B, Li L, Tang J, Ju J, Guan H, Song B. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer. Cancer Lett. 2019;459:122-134. [PMID: 31173853 DOI: 10.1016/j.canlet.2019.05.035] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
5 Kim DH, Kang HS, Kim KH. Roles of hepatocyte nuclear factors in hepatitis B virus infection. World J Gastroenterol 2016;22:7017-29. [PMID: 27610013 DOI: 10.3748/wjg.v22.i31.7017] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
6 Yang Z, Li J, Feng G, Wang Y, Yang G, Liu Y, Zhang S, Feng J, Zhang X. Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b. Cancer Biol Med 2019;16:276-87. [PMID: 31516748 DOI: 10.20892/j.issn.2095-3941.2018.0283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Lamontagne J, Mell JC, Bouchard MJ. Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression. PLoS Pathog 2016;12:e1005438. [PMID: 26891448 DOI: 10.1371/journal.ppat.1005438] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
8 Hou P, Zhao M, He W, He H, Wang H. Cellular microRNA bta-miR-2361 inhibits bovine herpesvirus 1 replication by directly targeting EGR1 gene. Vet Microbiol 2019;233:174-83. [PMID: 31176405 DOI: 10.1016/j.vetmic.2019.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
9 Li H, Wang Z, Li Y, Fang R, Wang H, Shi H, Zhang X, Zhang W, Ye L. Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells. J Biol Chem 2018;293:2053-65. [PMID: 29259128 DOI: 10.1074/jbc.M117.809582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Wang Y, Li Y. miR-146 promotes HBV replication and expression by targeting ZEB2. Biomed Pharmacother. 2018;99:576-582. [PMID: 29902868 DOI: 10.1016/j.biopha.2018.01.097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
11 Yu K, Shi G, Li N. The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright. Annals of Hepatology 2015;14:450-6. [DOI: 10.1016/s1665-2681(19)31165-2] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
12 Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma. World J Hepatol. 2018;10:558-570. [PMID: 30310534 DOI: 10.4254/wjh.v10.i9.558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
13 Ojha CR, Rodriguez M, Dever SM, Mukhopadhyay R, El-Hage N. Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections. J Biomed Sci 2016;23:74. [PMID: 27784307 DOI: 10.1186/s12929-016-0292-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
14 Wang Y, Tian H. miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines. Biochemical and Biophysical Research Communications 2017;487:167-72. [DOI: 10.1016/j.bbrc.2017.03.171] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
15 Naito Y, Tanaka Y, Ochiya T. microRNAs and Hepatitis B. Adv Exp Med Biol 2015;888:389-99. [PMID: 26663193 DOI: 10.1007/978-3-319-22671-2_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rana MA, Ijaz B, Daud M, Tariq S, Nadeem T, Husnain T. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC. Clin Res Hepatol Gastroenterol 2019;43:373-86. [PMID: 30377095 DOI: 10.1016/j.clinre.2018.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Dai X, Zhang W, Zhang H, Sun S, Yu H, Guo Y, Kou Z, Zhao G, Du L, Jiang S. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Res. 2014;42:6578-6590. [PMID: 24705650 DOI: 10.1093/nar/gku260] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
18 Shi Y, Du L, Lv D, Li Y, Zhang Z, Huang X, Tang H. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J Gastroenterol 2021;56:336-49. [PMID: 33665710 DOI: 10.1007/s00535-021-01765-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Santos RM, Moreno C, Zhang WC. Non-Coding RNAs in Lung Tumor Initiation and Progression. Int J Mol Sci 2020;21:E2774. [PMID: 32316322 DOI: 10.3390/ijms21082774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
20 Tan YL, Chen WN. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. World J Gastroenterol. 2014;20:5973-5986. [PMID: 24876720 DOI: 10.3748/wjg.v20.i20.5973] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
21 Sarkar N, Chakravarty R. Hepatitis B Virus Infection, MicroRNAs and Liver Disease. Int J Mol Sci. 2015;16:17746-17762. [PMID: 26247932 DOI: 10.3390/ijms160817746] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
22 Fan HX, Tang H. Complex interactions between microRNAs and hepatitis B/C viruses. World J Gastroenterol. 2014;20:13477-13492. [PMID: 25309078 DOI: 10.3748/wjg.v20.i37.13477] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
23 Mosca N, Castiello F, Coppola N, Trotta MC, Sagnelli C, Pisaturo M, Sagnelli E, Russo A, Potenza N. Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection. Biochem Biophys Res Commun. 2014;449:141-145. [PMID: 24824183 DOI: 10.1016/j.bbrc.2014.05.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
24 Chen X, Huang L. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction. PLoS Comput Biol 2017;13:e1005912. [PMID: 29253885 DOI: 10.1371/journal.pcbi.1005912] [Cited by in Crossref: 157] [Cited by in F6Publishing: 129] [Article Influence: 39.3] [Reference Citation Analysis]
25 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
26 Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res. 2016;2:163-186. [PMID: 28042609 DOI: 10.20517/2394-5079.2016.05] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
27 Lamontagne J, Steel LF, Bouchard MJ. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol. 2015;21:7375-7399. [PMID: 26139985 DOI: 10.3748/wjg.v21.i24.7375] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
28 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
29 Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 22.4] [Reference Citation Analysis]
30 Mizuguchi Y, Takizawa T, Uchida E. Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication. World J Hepatol. 2015;7:696-702. [PMID: 25866606 DOI: 10.4254/wjh.v7.i4.696] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
31 Gao H, Liu C. miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC. Biomedicine & Pharmacotherapy 2014;68:943-9. [DOI: 10.1016/j.biopha.2014.09.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
32 Naito Y, Hamada-Tsutsumi S, Yamamoto Y, Kogure A, Yoshioka Y, Watashi K, Ochiya T, Tanaka Y. Screening of microRNAs for a repressor of hepatitis B virus replication. Oncotarget 2018;9:29857-68. [PMID: 30042818 DOI: 10.18632/oncotarget.25557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Chen Z, Ye J, Ashraf U, Li Y, Wei S, Wan S, Zohaib A, Song Y, Chen H, Cao S. MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1. J Virol 2016;90:3722-34. [PMID: 26819305 DOI: 10.1128/JVI.03242-15] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
34 Huang D, Wang G, Zhang J, Li Y, Zeng X, Jiang N. MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma. Jpn J Clin Oncol 2015;45:738-44. [DOI: 10.1093/jjco/hyv063] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
35 Jiang Y, Han Q, Zhao H, Zhang J. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:435-50. [PMID: 34046368 DOI: 10.2147/JHC.S307962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Xie KL, Zhang YG, Liu J, Zeng Y, Wu H. MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics. 2014;4:1176-1192. [PMID: 25285167 DOI: 10.7150/thno.8715] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
37 Fan H, Lv P, Lv J, Zhao X, Liu M, Zhang G, Tang H. miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA. J Med Virol. 2017;89:834-844. [PMID: 27664977 DOI: 10.1002/jmv.24695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
38 Sanada T, Hirata Y, Naito Y, Yamamoto N, Kikkawa Y, Ishida Y, Yamasaki C, Tateno C, Ochiya T, Kohara M. Transmission of HBV DNA Mediated by Ceramide-Triggered Extracellular Vesicles. Cell Mol Gastroenterol Hepatol 2017;3:272-83. [PMID: 28275693 DOI: 10.1016/j.jcmgh.2016.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
39 Wu SY, Lan SH, Liu HS. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2016;22:176-87. [PMID: 26755869 DOI: 10.3748/wjg.v22.i1.176] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
40 Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y, Sanches J, Wang L, Du Y, Mao LM, Zuo SB, Liu HT, Shen J, Wang B, Hou L, Li LH, Tang JW, Ju JF, Guan HW, Song B. A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Mol Ther Nucleic Acids 2018;12:578-90. [PMID: 30195794 DOI: 10.1016/j.omtn.2018.06.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
41 Hao QQ, Wang QH, Xia W, Qian HZ. Circulating miRNA expression profile and bioinformatics analysis in patients with occult hepatitis B virus infection. J Med Virol 2020;92:191-200. [PMID: 31513283 DOI: 10.1002/jmv.25594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Xiu M, Zeng X, Shan R, Wen W, Li J, Wan R. The oncogenic role of HBXIP. Biomed Pharmacother 2021;133:111045. [PMID: 33378953 DOI: 10.1016/j.biopha.2020.111045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Li Y, Wu R, Liu Z, Fan J, Yang H. Enforced expression of microRNA-21 influences the replication of varicella-zoster virus by triggering signal transducer and activator of transcription 3. Exp Ther Med 2014;7:1291-6. [PMID: 24940427 DOI: 10.3892/etm.2014.1588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
44 Zhang X, Hou J, Lu M. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet. 2013;4:202. [PMID: 24133502 DOI: 10.3389/fgene.2013.00202] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
45 Guerrieri F, Belloni L, D'Andrea D, Pediconi N, Le Pera L, Testoni B, Scisciani C, Floriot O, Zoulim F, Tramontano A, Levrero M. Genome-wide identification of direct HBx genomic targets. BMC Genomics 2017;18:184. [PMID: 28212627 DOI: 10.1186/s12864-017-3561-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
46 Tian H, He Z. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity. Biomed Pharmacother 2018;99:774-80. [PMID: 29710475 DOI: 10.1016/j.biopha.2018.01.141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Sanches JGP, Xu Y, Yabasin IB, Li M, Lu Y, Xiu X, Wang L, Mao L, Shen J, Wang B, Hou L, Ju J, Zhao J, Song B. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD. Chemico-Biological Interactions 2018;285:85-95. [DOI: 10.1016/j.cbi.2018.02.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
48 Shi C, Xu X. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma. Biomed Pharmacother. 2013;67:375-380. [PMID: 23582783 DOI: 10.1016/j.biopha.2013.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
49 Louten J, Beach M, Palermino K, Weeks M, Holenstein G. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights. 2015;10:25-52. [PMID: 26819546 DOI: 10.4137/bmi.s29512] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
50 Xia Y, Guo H. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential. Antiviral Res. 2020;180:104824. [PMID: 32450266 DOI: 10.1016/j.antiviral.2020.104824] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
51 Kitab B, Alj HS, Ezzikouri S, Benjelloun S. MicroRNAs as Important Players in Host-hepatitis B Virus Interactions. J Clin Transl Hepatol 2015;3:149-61. [PMID: 26357642 DOI: 10.14218/JCTH.2015.00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
52 Bandopadhyay M, Bharadwaj M. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020;12:23. [PMID: 32346400 DOI: 10.1186/s13099-020-00353-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
53 Thirion M, Ochiya T. Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses. 2013;5:2690-2703. [PMID: 24212236 DOI: 10.3390/v5112690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]